摘要
目的:探究莫西沙星联合卷曲霉素治疗耐多药肺结核的临床效果。方法:2018年3月-2019年2月收治耐多药肺结核患者80例,随机分为两组,各40例。试验1组给予单独莫西沙星治疗;试验2组采取莫西沙星联合卷曲霉素治疗方法。比较两组治疗效果、不良反应发生情况。结果:试验2组治疗有效率明显优于试验1组,不良反应发生率明显低于试验1组,差异有统计学意义(P<0.05)。结论:采取莫西沙星联合卷曲霉素治疗耐多药肺结核能提高临床治疗效果,降低不良反应发生率,临床效果更显著。
Objective:To explore the clinical effect of moxifloxacin combined with capreomycin in the treatment of multi-drug resistant tuberculosis.Methods:80 patients with multi-drug resistant tuberculosis were sselected from March 2018 to February 2019,they were randomly divided into the two groups with 40 cases in each group.The the experiment group 1 was treated with moxifloxacin alone,while moxifloxacin combined with capreomycin was used in the experiment group 2.The therapeutic effect and adverse reactions were compared between the two groups.Results:The effective rate of treatment in the experimental group 2 was significantly higher than that in the experimental group 1,and the incidence of adverse reactions was significantly lower than that in the experimental group 1,and the differences were statistically significant(P<0.05).Conclusion:Moxifloxacin combined with capreomycin in the treatment of multi-drug resistant tuberculosis can improve the clinical effect,reduce the incidence of adverse reactions,and its clinical effect is more significant.
作者
胡小红
Hu Xiaohong(Hunan Provincial Chest Hospital,Hunan Changsha 410005)
出处
《中国社区医师》
2020年第14期25-25,27,共2页
Chinese Community Doctors
关键词
莫西沙星
卷曲霉素
耐多药肺结核
临床效果
Moxifloxacin
Capreomycin
Multi-drug resistant tuberculosis
Clinical effect